Stay updated on Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Sign up to get notified when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-14T00:57:34.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, indicating a new release with potentially significant changes, while the previous version v2.9.7 has been removed.
    Difference
    0.3%
    Check dated 2024-07-23T15:14:14.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7, replacing the previous version v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T09:14:20.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-11T01:40:14.000Z thumbnail image
  9. Check
    56 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-10T01:05:21.000Z thumbnail image
  10. Check
    62 days ago
    Change Detected
    Summary
    The value 'Ovarian Epithelial Cancer Fallopian Tube Cancer' has been changed to 'Fallopian Tube Cancer Ovarian Epithelial Cancer'. This represents a reversal in the order of the cancer types listed in the study title.
    Difference
    0.2%
    Check dated 2024-07-03T16:25:00.000Z thumbnail image

Stay in the know with updates to Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.